The U.S. Food and Drug Administration plans a “thorough investigation” of allegations about vulnerabilities in cardiac devices made by St. Jude Medical Inc, the agency's official responsible for cyber security said on Thursday. The FDA began its investigation in late August after short-selling firm Muddy Waters and cyber security firm MedSec Holdings Inc said they were betting St. Jude shares would fall, making allegations that its pacemakers and defibrillators have cyber security flaws that hackers could exploit to harm patients.
Read the original post:
U.S. health regulator plans ‘thorough’ probe of St. Jude case
